The SAVE Moms and Babies Act of 2026 would amend federal drug approval law to prohibit the Food and Drug Administration from approving any new abortion medications and from granting experimental use permits for abortion drugs. For abortion drugs already approved by the FDA, the bill would impose strict new requirements, including limiting use to the first 70 days of pregnancy and requiring in-person administration only at medical facilities by a certified physician—not through pharmacies or mail. Previously approved abortion drugs would need to comply with enhanced safety protocols, including mandatory reporting of adverse events and strict physician certification requirements. The bill also contains a provision that would automatically rescind any existing experimental drug permits for abortion medications three years after the law takes effect. While no specific funding is allocated in the bill itself, it would significantly expand FDA regulatory authority over medication abortion and establish reporting requirements that would affect patients, healthcare providers, and drug manufacturers.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.